Document Detail


Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
MedLine Citation:
PMID:  15378017     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The control exerted by the INK4a/ARF locus on cellular proliferation is crucial to restrict tumor development. In agreement with this, mice with defects in this locus are highly tumor prone. However, the potential contribution of other pathways in modulating tumorigenesis in the absence of INK4a/ARF is largely unexplored. In the present study, we investigated the consequences of the combined loss of either of two cyclin-dependent kinase inhibitors, p21 and p27, in cooperation with deletion of the INK4a/ARF locus. Our results show a clear differential effect in tumorigenesis depending on the CKI that is absent. The absence of p21 produced no overt alteration of the lifespan of the INK4a/ARF-null mice, although it modified their tumor spectrum, causing a significant increase in the incidence of fibrosarcomas and the appearance of a small number of rhabdomyosarcomas. In contrast, deficiency of p27 resulted in a significant increase in lethality due to accelerated tumor development, especially in the case of T-cell lymphomas. Finally, combined deficiency of INK4a/ARF and p27 resulted in a significant increase in the number of metastatic tumors. These results demonstrate genetically the oncogenic cooperation between defects on INK4a/ARF and p27, which are common alterations in human cancer.
Authors:
Juan Martín-Caballero; Juana M Flores; Pilar García-Palencia; Manuel Collado; Manuel Serrano
Related Documents :
17998647 - Heterogeneity in the radiosensitizing effects of the dna ligand hoechst-33342 in human ...
17043357 - Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via cdk phos...
10076567 - Growth inhibition of a549 human lung adenocarcinoma cells by l-canavanine is associated...
8313367 - Defective human retinoblastoma protein identified by lack of interaction with the e1a o...
2942037 - Endocrine aspects of human uterine sarcoma: a preliminary study.
9671317 - Analysis of the fhit gene and its product in squamous cell carcinomas of the head and n...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oncogene     Volume:  23     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-28     Completed Date:  2004-12-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  8231-7     Citation Subset:  IM    
Affiliation:
Molecular Oncology Program, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, Madrid E-28029, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
ADP-Ribosylation Factors / genetics*
Animals
Cell Cycle Proteins / genetics*
Cyclin-Dependent Kinase Inhibitor p16 / genetics*
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Cyclins / genetics*
Male
Mice
Mice, Inbred C57BL
Sequence Deletion*
Tumor Suppressor Proteins / genetics*
Chemical
Reg. No./Substance:
0/Cdkn1a protein, mouse; 0/Cdkn1b protein, mouse; 0/Cell Cycle Proteins; 0/Cyclin-Dependent Kinase Inhibitor p16; 0/Cyclin-Dependent Kinase Inhibitor p21; 0/Cyclins; 0/Tumor Suppressor Proteins; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; EC 3.6.5.2/ADP-Ribosylation Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.
Next Document:  RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and ...